Navigation Links
Cytokinetics announces fundamental research in cardiac myosin activation in the journal Science
Date:3/17/2011

South San Francisco, CA, March 18, 2011 Cytokinetics, Incorporated (Nasdaq: CYTK) announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure. This publication reveals, for the first time in a peer reviewed journal, the mechanism of action for omecamtiv mecarbil and the scientific rationale for directly modulating cardiac contractility as an innovative therapeutic strategy for improving cardiac performance in patients with heart failure.

"It is our honor to have Cytokinetics' novel scientific research into direct modulators of the cardiac contractile apparatus published in this prestigious journal," stated Fady I. Malik, MD, FACC, Cytokinetics' Vice President of Biology and Therapeutics and lead author of this report. "This publication summarizes the pioneering work performed by our dedicated research team that has supported the progression of our lead compound, omecamtiv mecarbil, through clinical development and now into Phase IIb clinical trials, which will be conducted by Amgen in collaboration with Cytokinetics."

The publication titled, "Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure," discusses the potential clinical role for therapies that directly activate cardiac myosin in the treatment of systolic heart failure. The authors recognized that decreased cardiac contractility is a central feature of systolic heart failure and that there is a need for more safe and effective treatment options to improve cardiac contractility. Existing drugs that increase cardiac contractility do so indirectly through signaling cascades but their use is limited by their mechanism-related adverse effects. Omecamtiv mecarbil, a small-molecule, direct
'/>"/>

Contact: Christopher Keenan
ckeenan@cytokinetics.com
415-505-2581
Cytokinetics, Inc.
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Chantel Lee ’15 and Eli Capello ... 40-hour weeks with Dr. Juan Rodriguez, Professor of Physics, in ... common diabetic eye disease caused by changes in the blood ... Eli accomplished is quite remarkable,” said Rodriguez. “They took on ... they started, and together carried it to near completion in ...
(Date:8/1/2014)... 01, 2014 Applied DNA Sciences, ... DNA-based anti-counterfeiting technology and product authentication solutions, will host ... discuss its fiscal third quarter results. The Quarterly Report ... by the end of the day on Monday August ... will host a conference call beginning at 9:00 A.M. ...
(Date:8/1/2014)... This is a professional and in-depth study on ... Global and China. The report provides a basic overview ... structure. Global market analysis and Chinese domestic market analysis ... and competitive landscape of the market. A comparison between ... The report also focuses on development policies and plans ...
(Date:8/1/2014)... 2014 Research and Markets  has ... Market for Flow Cytometry in IVD Applications" ... http://photos.prnewswire.com/prnh/20130307/600769 Flow cytometers are ... important component of advanced IVD labs in developed ... diagnostics, but their newer clinical applications included the ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 3Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 3The World Market for Flow Cytometry in IVD Applications 2
... 1, 2008 HighPoint Solutions,LLC, a premier provider of ... a global biotechnology company to design and implement,a Master ... new,product launches and support its expected rapid growth over ... strive to create a holistic view of,their customers in ...
... ARLINGTON, Va., April 1, 2008 Champions,Biotechnology, Inc. ... the,development of advanced preclinical platforms and tumor specific ... today the appointment of new,Board of Directors members ... it prepares to expand its operations., Abba ...
... Dr. Roger Kenneth,Hershline, PhD, MD, the CEO of Global ... charity CureHIV.us, announces today,that he is reaching out to ... Challenges in Global Health initiative. The,monies would be used ... treatment,method, LiSAVIOR., This unique new drug is also ...
Cached Biology Technology:HighPoint Solutions Selected by Global Biotechnology Company to Provide Master Data Management Solution 2Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 2Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 3Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 4Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 5Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 6Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 7Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 8Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR 2
(Date:8/1/2014)... collapses from a quantum superposition to a classical state or ... a quantum trajectory. For each start and end state there ... not as easy to predict the path or track it ... our everyday, classical world. , In a new paper featured ... from the Institute for Quantum Studies at Chapman University, the ...
(Date:8/1/2014)... species have been recorded into the Reptile Database, ... and classification, making the reptile species among the ... bird and fish species. , For some time, ... year that reptiles would become the most diverse ... lizards, turtles, crocodiles, tuataras and amphisbaenians. , "Officially, ...
(Date:8/1/2014)... humans appear in the fossil record about 200,000 years ... that making art and advanced tools became widespread. ... journal Current Anthropology finds that human skulls ... levels at around the same time that culture was ... making art and rapid cultural exchange probably came at ...
Breaking Biology News(10 mins):Mapping the optimal route between two quantum states 2Reptile Database surpasses 10,000 reptile species 2Reptile Database surpasses 10,000 reptile species 3Society bloomed with gentler personalities and more feminine faces 2
... Society of American Foresters has named Louisiana Tech University ... Gordon Holley as its 2012 Carl Alwin Schenck Award ... Society of Foresters National Convention held Oct. 24-28 in ... in the field of forestry education. This award recognizes ...
... , A whale that is almost unknown to science has been ... male calfwere stranded and died on a New Zealand beach. A ... a Cell Press publication, offers the first complete description of the ... only from a few bones. The discovery is the first ...
... to use tools in the wild has been observed spontaneously making ... Goffin,s cockatoo called ,Figaro, that has been reared in captivity and ... out of wooden beams in its aviary, or twigs out of ... reach. Researchers from the Universities of Oxford and Vienna filmed Figaro ...
Cached Biology News:Louisiana Tech University professor earns national honor from Society of American Foresters 2World's rarest whale seen for the first time 2Cockatoo 'can make its own tools' 2
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
... Polymorphic DNA Technologies also offers a ... variety of templates including plasmids, PCR products, ... with customer-provided templates such as purified plasmids ... throughput liquid handling robotics optimized for automated ...
... Polymerase is a premium quality recombinant form ... enzyme is suitable for a wide range ... purity and reproducible performance, each preparation is ... control assays. NovaTaq DNA Polymerase possesses an ...
... Parametric Analyzer and Sorter) large particle flow ... of flow cytometry to applications that were ... analysis and sorting. Our instruments are ... flow cytometers, but are designed to accommodate ...
Biology Products: